For most of a century, the power to create antibiotics resided almost exclusively in wealthy Western nations, shaping who lived and who died by the accident of geography. India has now entered this space not as a copier of existing medicines but as an originator of new ones, quietly redrawing the map of who holds the keys to antimicrobial innovation. This shift carries the possibility—not yet the guarantee—that the drugs the world needs most might finally reach the people who need them most.